Results 31 to 40 of about 32,558 (223)

Efficacy and safety of moxidectin, synriam, synriam-praziquantel versus praziquantel against schistosoma haematobium and S. mansoni infections: a randomized, exploratory phase 2 trial [PDF]

open access: yes, 2016
Schistosomiasis affects millions of people, yet treatment options are limited. The antimalarial Synriam (piperaquine 150 mg/arterolane 750 mg) and the anthelminthic moxidectin revealed promising antischistosomal properties in preclinical or clinical ...
Puchkov, Maxim   +23 more
core   +2 more sources

Is arachidonic acid an endoschistosomicide?

open access: yesJournal of Advanced Research, 2018
Schistosoma mansoni and Schistosoma haematobium are intravascular, parasitic flatworms that infect >250 million people in 70 developing countries, yet not all people of the same community and household are afflicted.
Violette Said Hanna   +4 more
doaj   +1 more source

Cytokine responses to Schistosoma haematobium in a Zimbabwean population: contrasting profiles for IFN-γ, IL-4, IL-5 and IL-10 with age [PDF]

open access: yes, 2007
Background The rate of development of parasite-specific immune responses can be studied by following their age profiles in exposed and infected hosts. This study determined the cytokine-age profiles of Zimbabweans resident in a Schistosoma haematobium ...
Mduluza Takafira   +17 more
core   +2 more sources

Schistosoma haematobiumInfection and Buruli Ulcer [PDF]

open access: yesEmerging Infectious Diseases, 2004
No abstract available.
Scott, Janet T.   +7 more
openaire   +4 more sources

Evaluation of the health-related quality of life of children in Schistosoma haematobium-endemic communities in Kenya: a cross-sectional study. [PDF]

open access: yes, 2013
BACKGROUND: Schistosomiasis remains a global public health challenge, with 93% of the ~237 million infections occurring in sub-Saharan Africa. Though rarely fatal, its recurring nature makes it a lifetime disorder with significant chronic health burdens.
Charles H. King (78462)   +44 more
core   +1 more source

Schistosoma haematobium

open access: yes, 2016
Prevalence of S. haematobium in persistent hot-spot and low-prevalence shehias Table 1 shows the prevalence of S. haematobium in children visiting the primary schools located in any of the seven study shehias, stratified by survey year. The average S. haematobium prevalence across all three survey years in 9 – 12 years old schoolchildren was 20.0 % (95
Pennance, Tom   +9 more
openaire   +2 more sources

Population Genetic Structure and Hybridization of Schistosoma haematobium in Nigeria

open access: yesPathogens, 2022
Background: Schistosomiasis is a major poverty-related disease caused by dioecious parasitic flatworms of the genus Schistosoma with a health impact on both humans and animals.
Amos Mathias Onyekwere   +6 more
doaj   +1 more source

Urinary bladder Schistosoma haematobium-related squamous cell carcinoma: a report of two fatal cases and literature review

open access: yesTropical Diseases, Travel Medicine and Vaccines, 2022
Background Schistosomiasis is still a public health issue in certain areas of developing countries (especially in sub-saharan Africa). Schistosoma haematobium is a proven carcinogenic agent that causes mainly bladder squamous cell carcinoma. This type of
Boubacar Efared   +6 more
doaj   +1 more source

Toward measuring Schistosoma response to praziquantel treatment with appropriate descriptors of egg excretion [PDF]

open access: yes, 2015
The control of schistosomiasis emphasizes preventive chemotherapy with praziquantel, which aims at decreasing infection intensity and thus morbidity in individuals, as well as transmission in communities.
Xiao-Nong Zhou (92570)   +70 more
core   +2 more sources

Whole-genome sequence of Schistosoma haematobium [PDF]

open access: yesNature Genetics, 2012
Schistosomiasis is a neglected tropical disease caused by blood flukes (genus Schistosoma; schistosomes) and affecting 200 million people worldwide. No vaccines are available, and treatment relies on one drug, praziquantel. Schistosoma haematobium has come into the spotlight as a major cause of urogenital disease, as an agent linked to bladder cancer ...
Young, Neil D.   +27 more
openaire   +5 more sources

Home - About - Disclaimer - Privacy